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MARIE CURIE NOBEL CENTENARY
Editor's Note
On November 6 to 8, 2003, Yale University held the "Marie Curie Nobel Centenary: Celebrating
Women in Science." The program stated: "This University-wide symposium is organized to celebrate
the centenary of the first award of the Nobel Prize to Marie Curie, within the broader context of an
examination of women in science. The conference will make visible the impact that women scien-
tists have historically had in their fields and address the challenges for the 21st Century."
The participants in this symposium included many distinguished scientists from outside Yale
including BruceAlberts, President ofthe NationalAcademy ofSciences; ShirleyTilghman, President
of Princeton University; Charles Vest, President of the Massachusetts Institute of Technology;
Jacqueline Barton, Professor ofChemistry at Caltech; Vera Rubin, Senior Researcher at the Carnegie
Institution, and scholars such as Brenda Maddox, author; and Helena Pycior, Professor ofHistory at
University ofWisconsin-Milwaukee.
Two ofthe papers presented at this symposium are published in this issue ofthe YaleJournal of
Biology andMedicine. Sara Rockwell, Professor ofTherapeutic Radiology atYale, writes on the life
and science of Marie Curie, and Elga Wasserman, Senior Scholar at the Yale Law School, writes on
the general issues facing women in science. In addition to these two symposium papers, the Classic
Paper for this issue is directly related to the medical aspects of the scientific discoveries of Marie
Curie.
Prior to the development of high-voltage X-ray generators in the mid to late 1930s, the only
source ofhigh energy radiation was the emanations of the naturally occurring radioactive elements.
Radium, discovered by Marie and Pierre Curie in 1898 as the active component of the naturally
radioactive mineral, pitchblende, was, for several decades, the only source of radiation for medical
investigations and treatments. The potentbiological effects ofradiation was observed by many ofthe
early researchers, including the discovererofnatural radi oactivity, Henri Becquerel, as well as Pierre
Curie, both of whom suffered radiation damage to the skin ("bums").
In 1906, two French scientists, Jean Bergonid and Louis Tribondeau published a very short note
("Interpretation of some results from radiotherapy and an attempt to determine a rational treatment
technique") in the weekly reports ofthe Paris Academy ofScience in which they put forth an expla-
nation for the biological actions ofradiations. They asserted that "X-rays are more effective on cells
which have a greater reproductive activity; the effectiveness is greater on those cells which have a
long lineage, on those cells the morphology and thefunction ofwhich are least definitivelyfixed. In
more modem terms," one might say "the radiation sensitivity of a tissue is inversely proportional to
its state of cellular differentiation." This simple principle, one that has been the guiding concept for
nearly a century in the fields ofbothradiotherapy as well as medical oncology, has come tobe known
as "The Law ofBergonie and Tribondeau." It even merits an entry in current medical dictionaries.
Jean Alban Bergonie (1857-1925) was a physician on the faculty ofthe University ofBordeaux
who was interested in medical physics and the biological effects ofelectricity and Louis Tribondeau
(1872-1918) was a histologist educated in the French Naval Medical School. Their complementary
interests and points of view can be seen in the reasoning and arguments put forth in their short but
influential and prescient communication almost a century ago.
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